ReviewInternational journal of molecular sciences2020

Candidate Strategies for Development of a Rapid-Acting Antidepressant Class That Does Not Result in Neuropsychiatric Adverse Effects: Prevention of Ketamine-Induced Neuropsychiatric Adverse Reactions.

Motohiro Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.